Recall events
/
Event 94265
Event summary
Timeline bucket March 19, 2024
Product types Drug
Classifications Class I
Statuses Ongoing
Recalling firm wording Pyramids Wholesale Inc.
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
11 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 11
Spanish Fly 22K capsules, 2-count box, UPC 0 664979 979455
D-0448-2024
Recall number D-0448-2024
Initiated March 19, 2024
Classification Class I
Status Ongoing
Quantity 45 boxes
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Distribution pattern Nationwide in the USA
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12379]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 11
Weiner Boner Honey, 12g packet, 100% Organic Formula.
D-0449-2024
Recall number D-0449-2024
Initiated March 19, 2024
Classification Class I
Status Ongoing
Quantity 19 boxes
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Distribution pattern Nationwide in the USA
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12166]
FDA event record
· Exact recall-number query on openFDA
drug · product 3 of 11
Flower Power, CBD infused Female Enhancement, 59 ml bottle, UPC 0 678741 351646.
D-0450-2024
Recall number D-0450-2024
Initiated March 19, 2024
Classification Class I
Status Ongoing
Quantity N/A
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Distribution pattern Nationwide in the USA
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12401]
FDA event record
· Exact recall-number query on openFDA
drug · product 4 of 11
Samurai-X Honey 6800, UPC 2 56891 27553 3.
D-0451-2024
Recall number D-0451-2024
Initiated March 19, 2024
Classification Class I
Status Ongoing
Quantity N/A
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Distribution pattern Nationwide in the USA
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12859]
FDA event record
· Exact recall-number query on openFDA
drug · product 5 of 11
Pink Pussycat Honey, net wt: 20gx12 sachets, UPC 7 918750 046557
D-0452-2024
Recall number D-0452-2024
Initiated March 19, 2024
Classification Class I
Status Ongoing
Quantity 149 boxes
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Distribution pattern Nationwide in the USA
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12402]
FDA event record
· Exact recall-number query on openFDA
drug · product 6 of 11
GoHARD 25000, Male Sexual Enhancement, Honey, 100% Natural, UPC: N/A.
D-0453-2024
Recall number D-0453-2024
Initiated March 19, 2024
Classification Class I
Status Ongoing
Quantity 12 boxes
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Distribution pattern Nationwide in the USA
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12864]
FDA event record
· Exact recall-number query on openFDA
drug · product 7 of 11
libigrow RED DRAGON+, Maximum Strength Formula, 2 capsules per box, UPC 7 05105 83073 5.
D-0454-2024
Recall number D-0454-2024
Initiated March 19, 2024
Classification Class I
Status Ongoing
Quantity 7 boxes
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Distribution pattern Nationwide in the USA
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12185]
FDA event record
· Exact recall-number query on openFDA
drug · product 8 of 11
SILVERBACK XXX POWER MALE ENHANCEMENT, 2 fl. oz., UPC 8 700470 032762
D-0455-2024
Recall number D-0455-2024
Initiated March 19, 2024
Classification Class I
Status Ongoing
Quantity 7 pieces
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Distribution pattern Nationwide in the USA
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13201]
FDA event record
· Exact recall-number query on openFDA
drug · product 9 of 11
The GOAT SUBLINGUAL STRIP, MALE ENHANCEMENT, 2 Pack, Distributed by Hombres LLC, 130 Maccormick Ave, Suite 105, Costa Mesa, A, UPC 6 61631 26363 1.
D-0456-2024
Recall number D-0456-2024
Initiated March 19, 2024
Classification Class I
Status Ongoing
Quantity 10 boxes
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Distribution pattern Nationwide in the USA
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[13209]
FDA event record
· Exact recall-number query on openFDA
drug · product 10 of 11
ALPHASTRIP MALE PERFORMANCE ENHANCER, The fastest acting sublingual, Serving Size (1 strip), Distributed by: GALT INT'L
D-0457-2024
Recall number D-0457-2024
Initiated March 19, 2024
Classification Class I
Status Ongoing
Quantity 4,351 pieces
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Distribution pattern Nationwide in the USA
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12824]
FDA event record
· Exact recall-number query on openFDA
drug · product 11 of 11
HONEY MANUKA BUNNY LOVE, 12g, All Natural Sexual Enhancement, UPC: N/A
D-0458-2024
Recall number D-0458-2024
Initiated March 19, 2024
Classification Class I
Status Ongoing
Quantity 19 boxes
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and/or tadalafil.
Distribution pattern Nationwide in the USA
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[12175]
FDA event record
· Exact recall-number query on openFDA
